Pharmacology Biochemistry And Behavior

Journal Title：Pharmacology Biochemistry And Behavior

Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely biochemical or toxicology studies will not be published. Papers describing the behavioral effects of novel drugs in models of psychiatric, neurological and cognitive disorders, and central pain must include a positive control unless the paper is on a disease where such a drug is not available yet. Papers focusing on physiological processes (e.g., peripheral pain mechanisms, body temperature regulation, seizure activity) are not accepted as we would like to retain the focus of Pharmacology Biochemistry & Behavior on behavior and its interaction with the biochemistry and neurochemistry of the central nervous system. Papers describing the effects of plant materials are generally not considered, unless the active ingredients are studied, the extraction method is well described, the doses tested are known, and clear and definite experimental evidence on the mechanism of action of the active ingredients is provided.

《药理学生物化学与行为》发表药理学和生物化学领域的原创报告，主要侧重点和理论背景是行为。投稿可能涉及临床、临床前或基础研究。纯生物化学或毒理学研究将不予发表。描述新型药物在精神、神经和认知障碍以及中枢疼痛模型中的行为影响的论文必须包括阳性对照，除非该论文研究的疾病尚无此类药物。我们不接受关注生理过程（例如外周疼痛机制、体温调节、癫痫发作）的论文，因为我们希望将《药理学生物化学与行为》的重点放在行为及其与中枢神经系统的生物化学和神经化学的相互作用上。描述植物材料影响的论文通常不予考虑，除非研究了活性成分、很好地描述了提取方法、已知测试剂量并提供了关于活性成分作用机制的明确实验证据。

Pharmacology Biochemistry And Behavior创刊于1973年，由Elsevier Inc.出版商出版，收稿方向涵盖医学 - 行为科学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 一般,3-6周 ，影响因子指数3.3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。